Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.
paper
Cited
Public
Unavailable
- Authors
- Lynch, M E; Ware, Mark A
- Year
- 2015
- Journal
- Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
- PMID
- 25796592
- DOI
- 10.1007/s11481-015-9600-6
An updated systematic review of randomized controlled trials examining cannabinoids in the treatment of chronic non-cancer pain was conducted according to PRISMA guidelines for systematic reviews reporting on health care outcomes. Eleven trials published since our last review met inclusion criteria. The quality of the trials was excellent. Seven of the trials demonstrated a significant analgesic effect. Several trials also demonstrated improvement in secondary outcomes (e.g., sleep, muscle stiffness and spasticity). Adverse effects most frequently reported such as fatigue and dizziness were mild to moderate in severity and generally well tolerated. This review adds further support that currently available cannabinoids are safe, modestly effective analgesics that provide a reasonable therapeutic option in the management of chronic non-cancer pain.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| ATTITUDES AND PRACTICE PATTERNS OF CANADIAN PHYSIATRISTS REGARDING MEDICAL CANNABIS. | Ethans K et al. | โ | 2025 | โ |
| Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential. | Walczyลska-Dragon K et al. | โ | 2025 | โ |
| Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain. | Khak M et al. | โ | 2025 | โ |
| Does Cannabis-based Medicine Improve Pain and Sleep Quality in Patients With Traumatic Brachial Plexus Injuries? A Triple-blind, Crossover, Randomized Controlled Trial. | Kittithamvongs P et al. | โ | 2025 | โ |
| Exploring Natural Analgesics for Chronic Pain Management: Cannabinoids and other Phytoconstituents. | Bjรธrklund G et al. | โ | 2025 | โ |
| Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer. | Tehranchi K et al. | โ | 2025 | โ |
| Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review. | Al-Husinat L et al. | โ | 2025 | โ |
| US State Recreational and Medical Cannabis Delivery Laws, 2024. | Ebling T et al. | โ | 2025 | โ |
| Cannabis Use Is Associated With Fewer Filled Opioid Prescriptions After Treatment of Proximal Humerus Fractures. | Silver J et al. | โ | 2024 | โ |
| Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts. | Mick G et al. | โ | 2024 | โ |
| Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. | Bell AD et al. | โ | 2024 | โ |
| Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations. | Lapteva M et al. | โ | 2024 | โ |
| Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis. | Serag I et al. | โ | 2024 | โ |
| Narrative bias ("spin") is common in randomised trials and systematic reviews of cannabinoids for pain. | Moore A et al. | โ | 2024 | โ |
| Risks associated with chronic cannabis use on opioid use, length of stay, and revision rate for patients undergoing posterior lumbar interbody fusion. | Brenne J et al. | โ | 2024 | โ |
| Synthesis and Antiallodynic Activity of Cannabidiol Analogue on Peripheral Neuropathy in Mice. | Marques GVL et al. | โ | 2024 | โ |
| The Effects of Nicotine and Cannabinoids on Cytokines. | Miller G et al. | โ | 2024 | โ |
| Understanding the Orthopedic Conditions for Which Patients Are Seeking Medical Cannabis Certification. | Chung J et al. | โ | 2024 | โ |
| Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation. | Healy CR et al. | โ | 2023 | โ |
| Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis. | Ince HY et al. | โ | 2023 | โ |
| Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB<sub>2</sub> receptor agonists. | Mahardhika AB et al. | โ | 2023 | โ |
| Evaluation and Treatment of Vulvodynia: State of the Science. | Schlaeger JM et al. | โ | 2023 | โ |
| Medical Cannabis: A Review from the American Society of Pain and Neuroscience. | Strand N et al. | โ | 2023 | โ |
| Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews. | O'Neill V et al. | โ | 2023 | โ |
| Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study. | Poisblaud L et al. | โ | 2023 | โ |
| Cannabis and orofacial pain: a systematic review. | Grossman S et al. | โ | 2022 | โ |
| Cannabis and pain: a scoping review. | Pantoja-Ruiz C et al. | โ | 2022 | โ |
| Cannabis Cessation, Inflammatory Markers and Schizophrenia. | Romeo B et al. | โ | 2022 | โ |
| Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews. | Riera R et al. | โ | 2022 | โ |
| Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review. | Cheng KYC et al. | โ | 2022 | โ |
| Hemp Seeds of the Polish 'Bialobrzeskie' and 'Henola' Varieties (<i>Cannabis sativa</i> L. var. <i>sativa</i>) as Prospective Plant Sources for Food Production. | Teleszko M et al. | โ | 2022 | โ |
| Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis. | Renslo B et al. | โ | 2022 | โ |
| Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer. | Oberoi S et al. | โ | 2022 | โ |
| Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us? | Vila Silvรกn C et al. | โ | 2022 | โ |
| Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. | Legare CA et al. | โ | 2022 | โ |
| The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians. | Kรถstenberger M et al. | โ | 2022 | โ |
| Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. | Moore RA et al. | โ | 2021 | โ |
| Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study. | Schrรคder NHB et al. | โ | 2021 | โ |
| Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. | Furrer D et al. | โ | 2021 | โ |
| Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials. | Longo R et al. | โ | 2021 | โ |
| Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study. | Lucas P et al. | โ | 2021 | โ |
| Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review. | Eadie L et al. | โ | 2021 | โ |
| Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis. | Sainsbury B et al. | โ | 2021 | โ |
| GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds. | Ahmed M et al. | โ | 2021 | โ |
| Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials. | Dykukha I et al. | โ | 2021 | โ |
| Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain. | Henderson-Redmond AN et al. | โ | 2021 | โ |
| State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort. | Lopez CD et al. | โ | 2021 | โ |
| The Role of Organic Small Molecules in Pain Management. | Cuesta SA et al. | โ | 2021 | โ |
| Traditional uses of Cannabis: An analysis of the CANNUSE database. | Balant M et al. | โ | 2021 | โ |
| 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands. | Penthala NR et al. | โ | 2020 | โ |
| Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression. | Wong SSC et al. | โ | 2020 | โ |
| Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. | Wright P et al. | โ | 2020 | โ |
| Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review. | Mun CJ et al. | โ | 2020 | โ |
| Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. | Gonen T et al. | โ | 2020 | โ |
| Cannabis and Pain Treatment-A Review of the Clinical Utility and a Practical Approach in Light of Uncertainty. | Vulfsons S et al. | โ | 2020 | โ |
| Cannabis and Vulvodynia Symptoms: A Preliminary Report. | Barach E et al. | โ | 2020 | โ |
| Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. | Inglet S et al. | โ | 2020 | โ |
| Epileptic Spikes in EEG and Migraine Attacks in the Course of Cannabis Withdrawal: A Case Report. | Adorjan K et al. | โ | 2020 | โ |
| Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks. | Bergeria CL et al. | โ | 2020 | โ |
| Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. | Pinson A et al. | โ | 2020 | โ |
| Safety Considerations in Cannabinoid-Based Medicine. | Gottschling S et al. | โ | 2020 | โ |
| Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications. | Haack M et al. | โ | 2020 | โ |
| The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. | Rabgay K et al. | โ | 2020 | โ |
| Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. | Baswan SM et al. | โ | 2020 | โ |
| Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews. | Montero-Oleas N et al. | โ | 2020 | โ |
| Use of oral cannabis extracts in the pediatric palliative care setting: A retrospective chart review. | Doherty M et al. | โ | 2020 | โ |
| Advances in the Understanding and Management of Chronic Pain in Multiple Sclerosis: a Comprehensive Review. | Urits I et al. | โ | 2019 | โ |
| A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. | Jacobson MR et al. | โ | 2019 | โ |
| Attitudes of Irish patients with chronic pain towards medicinal cannabis. | Rochford C et al. | โ | 2019 | โ |
| Benefits and harms of medical cannabis: a scoping review of systematic reviews. | Pratt M et al. | โ | 2019 | โ |
| Canadian dog owners' use and perceptions of cannabis products. | Kogan LR et al. | โ | 2019 | โ |
| Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. | Blanton HL et al. | โ | 2019 | โ |
| Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. | Hutchison KE et al. | โ | 2019 | โ |
| Cannabis for pain in orthopedics: a systematic review focusing on study methodology | Madden K et al. | โ | 2019 | โ |
| Effects of cannabinoid administration for pain: A meta-analysis and meta-regression. | Yanes JA et al. | โ | 2019 | โ |
| Opportunities for cannabis in supportive care in cancer. | Kleckner AS et al. | โ | 2019 | โ |
| Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with ฮ<sup>9</sup>-Tetrahydrocannabinol and JWH-018. | Ford BM et al. | โ | 2019 | โ |
| The Associations of Neighborhood Availability of Marijuana Dispensaries and DATA-2000 Waivered Providers with Hospital Stays Related to Opioids. | Liang D et al. | โ | 2019 | โ |
| The endocannabinoid system: Novel targets for treating cancer induced bone pain. | Sun J et al. | โ | 2019 | โ |
| Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. | Campbell G et al. | โ | 2019 | โ |
| Antinociceptive effects of JWH015 in female and male rats. | Craft RM et al. | โ | 2018 | โ |
| Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. | Bradford AC et al. | โ | 2018 | โ |
| Associations between medical cannabis and other drug use among unstably housed women. | Meacham MC et al. | โ | 2018 | โ |
| Cannabinoids and Pain: New Insights From Old Molecules. | Vuฤkoviฤ S et al. | โ | 2018 | โ |
| Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain. | Mondello E et al. | โ | 2018 | โ |
| Cannabinoids for Treatment of MS Symptoms: State of the Evidence. | Rice J et al. | โ | 2018 | โ |
| Cannabinoids in the Management of Musculoskeletal Pain: A Critical Review of the Evidence. | Madden K et al. | โ | 2018 | โ |
| Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. | Abdallah SJ et al. | โ | 2018 | โ |
| Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. | Hรคuser W et al. | โ | 2018 | โ |
| Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014. | Liang D et al. | โ | 2018 | โ |
| Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs. | Cerdรก M et al. | โ | 2018 | โ |
| Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. | Baron EP | โ | 2018 | โ |
| Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. | Nugent SM et al. | โ | 2018 | โ |
| Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. | Baron EP et al. | โ | 2018 | โ |
| Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain. | Sharon H et al. | โ | 2018 | โ |
| Preface to DMR special edition 'Cannabinoid receptors and ligands: therapeutic drug development and abuse potential'. | Prather PL | โ | 2018 | โ |
| Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. | Bellnier T et al. | โ | 2018 | โ |
| Self-Reported Effectiveness and Safety of Trokie<sup>ยฎ</sup> Lozenges: A Standardized Formulation for the Buccal Delivery of Cannabis Extracts. | Crowley K et al. | โ | 2018 | โ |
| Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. | Cooper ZD et al. | โ | 2018 | โ |
| Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms. | Allan GM et al. | โ | 2018 | โ |
| The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. | Donvito G et al. | โ | 2018 | โ |
| Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients. | Bryant LM et al. | โ | 2018 | โ |
| US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions. | Kogan L et al. | โ | 2018 | โ |
| Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. | Yuill MB et al. | โ | 2017 | โ |
| A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain. | Stevens AJ et al. | โ | 2017 | โ |
| Cannabidiol-ฮ<sup>9</sup>-tetrahydrocannabinol interactions on acute pain and locomotor activity. | Britch SC et al. | โ | 2017 | โ |
| Cannabinoids and Pain: Sites and Mechanisms of Action. | Starowicz K et al. | โ | 2017 | โ |
| Cannabinoids in Pain Management and Palliative Medicine. | Hรคuser W et al. | โ | 2017 | โ |
| Cannabis, Cannabinoids, and Sleep: a Review of the Literature. | Babson KA et al. | โ | 2017 | โ |
| Characterization of structurally novel G protein biased CB<sub>1</sub> agonists: Implications for drug development. | Ford BM et al. | โ | 2017 | โ |
| Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery. | Bort A et al. | โ | 2017 | โ |
| International Olympic Committee consensus statement on pain management in elite athletes. | Hainline B et al. | โ | 2017 | โ |
| Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. | Klieger SB et al. | โ | 2017 | โ |
| Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. | Shi Y | โ | 2017 | โ |
| Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement. | Mu A et al. | โ | 2017 | โ |
| Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus. | Park A et al. | โ | 2017 | โ |
| Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis. | Meng H et al. | โ | 2017 | โ |
| A user's guide to cannabinoid therapies in oncology. | Maida V et al. | โ | 2016 | โ |
| Cannabis in Pain Treatment: Clinical and Research Considerations. | Savage SR et al. | โ | 2016 | โ |
| Cannabis sativa: The Plant of the Thousand and One Molecules. | Andre CM et al. | โ | 2016 | โ |
| High-resolution crystal structure of the human CB1 cannabinoid receptor. | Shao Z et al. | โ | 2016 | โ |
| Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. | Paice JA et al. | โ | 2016 | โ |
| Medical cannabis: considerations for the anesthesiologist and pain physician. | Beaulieu P et al. | โ | 2016 | โ |
| Nabilone for the Management of Pain. | Tsang CC et al. | โ | 2016 | โ |
| Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. | Hess C et al. | โ | 2016 | โ |
| Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. | Leitl MD et al. | โ | 2016 | โ |
| Sex differences in cannabinoid-regulated biology: A focus on energy homeostasis. | Wagner EJ | โ | 2016 | โ |
| The effect of medical cannabis laws on juvenile cannabis use. | Stolzenberg L et al. | โ | 2016 | โ |
| Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. | Xie J et al. | โ | 2016 | โ |
| Managing Chronic Pain in Children and Adolescents: A Clinical Review. | Landry BW et al. | โ | 2015 | โ |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | โ | 2015 | โ |
| Prescribing marijuana for chronic pain. | Ladouceur R | โ | 2015 | โ |
| Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. | Sznitman SR et al. | โ | 2015 | โ |
| Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. | Cabral GA et al. | โ | 2015 | โ |